References
Trial protocol and statistical analysis planClick here for additional data file.eTable 1. Analysis of primary outcome at multiple time pointseTable 2. Patients that lost ≥ 5%, ≥ 10% and ≥ 15% of their body weight at 24 weekseTable 3. Baseline values for functional capacity tests, BDI score, IWQOL-Lite score, IPAQ activity and EQ-53-3L scoreeTable 4. Analysis of physical function tests between baseline and week 24eTable 5. Analysis of IPAQ questionnaire between baseline and week 24eTable 6. Analysis of IQWOL-Lite and components between baseline and week 24eFigure 1. Trial designeFigure 2. Analysis of change in weight at multiple time points (kg)eFigure 3. Effect of liraglutide 3.0mg once daily and placebo on categorical weight lossClick here for additional data file.Data sharing statementClick here for additional data file.